Ligand Pharmaceuticals
LGND
#2805
Rank
โ‚ฌ5.36 B
Marketcap
269,34ย โ‚ฌ
Share price
2.31%
Change (1 day)
71.82%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total debt

Total debt on the balance sheet as of June 2026 : โ‚ฌ1.00 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total debt is โ‚ฌ1.00 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Ligand Pharmaceuticals - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚ฌ0.38 B5548.16%
2024-12-31โ‚ฌ6.8 M22.02%
2023-12-31โ‚ฌ5.57 M-93.18%
2022-12-31โ‚ฌ81.8 M-71.44%
2021-12-31โ‚ฌ0.28 B-22.81%
2020-12-31โ‚ฌ0.37 B-36.07%
2019-12-31โ‚ฌ0.58 B4.35%
2018-12-31โ‚ฌ0.55 B197.23%
2017-12-31โ‚ฌ0.18 B-7.55%
2016-12-31โ‚ฌ0.20 B9.57%
2015-12-31โ‚ฌ0.18 B14.68%
2014-12-31โ‚ฌ0.16 B2342.14%
2013-12-31โ‚ฌ6.59 M-69.15%
2012-12-31โ‚ฌ21.37 M-8.33%
2011-12-31โ‚ฌ23.32 M35.75%
2010-12-31โ‚ฌ17.17 M-32.15%
2009-12-31โ‚ฌ25.31 M-31.31%
2008-12-31โ‚ฌ36.86 M2397.47%
2007-12-31โ‚ฌ1.47 M-95.37%
2006-12-31โ‚ฌ31.88 M-78.16%
2005-12-31โ‚ฌ0.14 B13.79%
2004-12-31โ‚ฌ0.12 B-6.39%
2003-12-31โ‚ฌ0.13 B-8.95%
2002-12-31โ‚ฌ0.15 B-6.47%
2001-12-31โ‚ฌ0.16 B12.15%
2000-12-31โ‚ฌ0.14 B2.56%
1999-12-31โ‚ฌ0.13 B77.21%
1998-12-31โ‚ฌ78.96 M72.88%
1997-12-31โ‚ฌ45.67 M-4.24%
1996-12-31โ‚ฌ47.69 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ43.75 B 4,233.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ56.39 B 5,485.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ48.99 B 4,752.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ51.13 B 4,964.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ8.62 B 754.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ48.10 B 4,664.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ40.20 B 3,881.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ21.56 B 2,035.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
โ‚ฌ25.73 M-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA